Psychiatry and Behavioral Sciences

Through a career in academic, public policy, clinical, and administrative roles, Dr. McQuistion’s expertise concerns community-based systems of care. He has extensively published and taught on community mental health and the needs of marginalized populations, especially regarding recovery orientation, advocacy, clinical engagement, psychiatric rehabilitation, and substance misuse. He completed Residency at NYU Medical Center and the Public Psychiatry Fellowship at Columbia. He is past president of the American Association for Community Psychiatry, recipient of the National Alliance on Mental Illness Exemplary Psychiatrist Award, Fellow of the New York Academy of Medicine, and Distinguished Life Fellow of the American Psychiatric Association.

Dr. Carolina Herrera Ortiz appears to be a clinician or psychiatrist whose practice includes neurodevelopmental disorders like ADHD, as well as other mental health areas such as anxiety, depression, and sleep issues. She emphasizes a personalized and integrative approach to mental health addressing the individual needs of patients across the lifespan. Her plenary focus on motherhood and ADHD suggests expertise in how attention-related challenges in either parents or children influence parenting experiences and child development a theme connected to research on parental stress and child neurodevelopment. (General research shows that parenting children with ADHD is associated with greater parenting stress and specific family challenges.

Nora Volkow, M.D., is a globally recognized psychiatrist and neuroscientist best known for transforming the understanding of addiction as a chronic brain disorder rather than a moral failing. She has served as Director of the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), since 2003, where she oversees and advances research on the health impacts of drug use and substance use disorders. Born in Mexico City, Dr. Volkow earned her medical degree from the National Autonomous University of Mexico and completed her psychiatric residency at New York University. She pioneered the use of brain imaging technologies, particularly PET scans, to study how drugs affect dopamine pathways and brain regions involved in reward, motivation, and self-control. Her groundbreaking research has significantly shaped public health policies and clinical approaches to addiction treatment, while also contributing to broader insights into conditions such as ADHD, obesity, and aging. Through her scientific leadership and advocacy, Dr. Volkow continues to influence global strategies for addressing substance use and advancing neuroscience research.

Gregory Keane is an Australian psychiatrist with extensive experience in humanitarian mental health and emergency response. He has worked with Médecins Sans Frontières (Doctors Without Borders), supporting communities affected by conflict, displacement, and crisis, particularly in the Middle East. His work focuses on integrating mental health care into humanitarian settings, strengthening local health systems, and addressing trauma in vulnerable populations. Dr. Keane combines clinical expertise with public health and policy experience to improve psychiatric responses during humanitarian emergencies.